title: Netilmicin withdrawal: impact on neonates.
authors.forename: Catherine M T
authors.initials: CM
authors.lastname: Sherwin
authors.forename: Sofia
authors.initials: S
authors.lastname: Svahn
authors.forename: Roland S
authors.initials: RS
authors.lastname: Broadbent
authors.forename: Antje
authors.initials: A
authors.lastname: Van Der Linden
authors.forename: Natalie J
authors.initials: NJ
authors.lastname: Medlicott
authors.forename: David M
authors.initials: DM
authors.lastname: Reith
mesh_terms: D000583:Amikacin / Q000008:administration & dosage / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004335:Drug and Narcotic Control; D006801:Humans; D007231:Infant, Newborn; D008485:Medical Audit; D009428:Netilmicin / Q000008:administration & dosage* / Q000009:adverse effects; D009520:New Zealand; D012189:Retrospective Studies; D018805:Sepsis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013292:Streptococcus agalactiae; D017211:Treatment Failure
chemical_list: D000900:Anti-Bacterial Agents; D009428:Netilmicin; D000583:Amikacin